原发性醛固酮增多症的靶器官损害及治疗

被引：11

作者：

莫剑梅

黄荣杰

机构：

[1] 广西医科大学心血管病研究所高血压病区

来源：

医学综述 | 2013年 / 19卷 / 07期

关键词：

原发性醛固酮增多症; 高血压; 靶器官损害; 治疗;

D O I：

暂无

中图分类号：

R544.15 [];

学科分类号：

摘要：

原发性醛固酮增多症(PA)是继发性高血压的常见病因,也是顽固性高血压的原因之一。由于高醛固酮血症及低肾素活性的影响,水钠潴留及血管内皮的炎症改变导致血压升高,动脉硬化及心脏、脑、肾脏靶器官损害,使心血管事件的发生率增加。关于PA患者的治疗,降低血压、治疗高醛固酮血症、盐皮质激素受体、手术及醛固酮受体拮抗剂的应用都是有效的方法,有助于减少患者的心血管疾病风险。

引用

收藏

页码：1226 / 1228

页数：3

相关论文

共 17 条

[1]

802例高血压患者中原发性醛固酮增多症83例临床分析.[J].胡淑芳;.临床内科杂志.2010, 11

[2]

Improved Quality of Life, Blood Pressure, and Biochemical Status Following Laparoscopic Adrenalectomy for Unilateral Primary Aldosteronism [J].

Sukor, Norlela ;

Kogovsek, Cynthia ;

Gordon, Richard D. ;

Robson, Dianne ;

Stowasser, Michael .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (03) :1360-1364

[3]

Role of Unilateral Adrenalectomy in Bilateral Primary Aldosteronism: A 22-Year Single Center Experience [J].

Sukor, Norlela ;

Gordon, Richard D. ;

Ku, Yee Kim ;

Jones, Mark ;

Stowasser, Michael .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07) :2437-2445

[4]

Elevated Serum Interleukin 6 Levels in Normotensive Individuals With Familial Hyperaldosteronism Type 1 [J].

Staermose, Sandie ;

Marwick, Thomas H. ;

Gordon, Richard D. ;

Cowley, Diane ;

Dowling, Alison ;

Stowasser, Michael .

HYPERTENSION, 2009, 53 (04) :E31-E32

[5]

Intrarenal Hemodynamics in Primary Aldosteronism before and after Treatment [J].

Sechi, Leonardo A. ;

Di Fabio, Alessandro ;

Bazzocchi, Massimo ;

Uzzau, Alessandro ;

Catena, Cristiana .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) :1191-1197

[6]

Cardiovascular and Cerebrovascular Comorbidities of Hypokalemic and Normokalemic Primary Aldosteronism: Results of the German Conn's Registry [J].

Born-Frontsberg, E. ;

Reincke, M. ;

Rump, L. C. ;

Hahner, S. ;

Diederich, S. ;

Lorenz, R. ;

Allolio, B. ;

Seufert, J. ;

Schirpenbach, C. ;

Beuschlein, F. ;

Bidlingmaier, M. ;

Endres, S. ;

Quinkler, M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (04) :1125-1130

[7]

Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism [J].

Bernini, Giampaolo ;

Galetta, Fabio ;

Franzoni, Ferdinando ;

Bardini, Michele ;

Taurino, Chiara ;

Bernardini, Melania ;

Ghiadoni, Lorenzo ;

Bernini, Matteo ;

Santoro, Gino ;

Salvetti, Antonio .

JOURNAL OF HYPERTENSION, 2008, 26 (12) :2399-2405

[8]

Case detection, diagnosis, and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline [J].

Funder, John W. ;

Carey, Robert M. ;

Fardella, Carlos ;

Gomez-Sanchez, Celso E. ;

Mantero, Franco ;

Stowasser, Michael ;

Young, William F., Jr. ;

Montori, Victor M. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) :3266-3281

[9]

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism [J].

Karagiannis, Asterios ;

Tziomalos, Konstantinos ;

Papageorgiou, Athanasios ;

Kakafika, Anna I. ;

Pagourelias, Efstathios D. ;

Anagnostis, Panagiotis ;

Athyros, Vasilios G. ;

Miailidis, Dimitri P. .

EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (04) :509-515

[10]

Effects of aldosterone on the vasculature [J].

Schiffrin, EL .

HYPERTENSION, 2006, 47 (03) :312-318